Back
LSB Industries 10K Form
Sell
44
LXU
LSB Industries
Last Price:
8.24
Seasonality Move:
4.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-02 | 10Q | LXU/LSB Industries Quarterly |
2023-07-27 | 10Q | LXU/LSB Industries Quarterly |
2023-05-03 | 10Q | LXU/LSB Industries Quarterly |
2022-11-02 | 10Q | LXU/LSB Industries Quarterly |
2022-07-28 | 10Q | LXU/LSB Industries Quarterly |
2022-05-04 | 10Q | LXU/LSB Industries Quarterly |
Receive LXU News And Ratings
See the #1 stock for the next 7 days that we like better than LXU
LXU Financial Statistics
Sales & Book Value
Annual Sales: | $593.71M |
---|---|
Cash Flow: | $-9.48M |
Price / Cash Flow: | 8.8 |
Annual Sales: | $7.09 |
Price / Book: | 1.16 |
Profitability
EPS (TTM): | 0.37000 |
---|---|
Net Income (TTM): | $27.92M |
Gross Margin: | $86.26M |
Return on Equity: | 5.3% |
Return on Assets: | 2.06% |
LSB Industries Earnings Forecast
Key LSB Industries Financial Ratios
- The Gross Profit Margin over the past 40 years for LXU is 14.53%.
- The Selling, General & Administrative Expenses for LXU have been equal to 6.16% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 147.32% of Operating Income.
- The Net Earning history of LXU is 4.70% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 19 years.
LSB Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | LXU |
CUSIP: | 502160 |
Website: | lsbindustries.com |
Debt
Debt-to-Equity Ratio: | 1.15 |
---|---|
Current Ratio: | 3.68 |
Quick Ratio: | 2.92 |
Price-to-Earnings
Trailing P/E Ratio: | 22.19 |
---|---|
Forward P/E Ratio: | 22.8 |
LXU Technical Analysis vs Fundamental Analysis
Sell
44
LSB Industries (LXU)
is a Sell
Is LSB Industries a Buy or a Sell?
-
LSB Industries stock is rated a Sell
The current LSB Industries [LXU] share price is $8.21. The Score for LXU is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.